Fin Trust Capital Advisors, LLC Inovio Pharmaceuticals, Inc. Transaction History

Fin Trust Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$1.44 - $3.98 $861 - $2,380	-598 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $6,230 - $10,030	-1,000 Reduced 62.58%	598 $6,000
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $8,810 - $16,960	1,000 Added 167.22%	1,598 $15,000
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $1,530 - $2,313	-180 Reduced 23.14%	598 $5,000
Q3 2020 Nov 10, 2020	BUY	$9.57 - $27.05 $1,722 - $4,869	180 Added 30.1%	778 $9,000
Q2 2020 Sep 11, 2020	BUY	$7.14 - $31.69 $4,269 - $18,950	598 New	598 $16,000
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $4,269 - $18,950	-598 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $1,782 - $8,425	598 New	598 $4,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.06B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.